Cowen strengthens its Equity Capital Markets team with the appointment of Brian Hagerty as Managing Director, Biotechnology


Enter Wall Street with StreetInsider Premium. Claim your one week free trial here.


NEW YORK, Feb. 28 11, 2022 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ: COWN) (“Cowen” or the “Company”) today announced that Brian Hagerty has joined the firm’s Equity Capital Markets team as a Managing Director on biotechnology. Mr. Hagerty will be based in New York and will report to Grant Miller, Managing Director and Head of Capital Markets, and will work closely with Cowen’s senior healthcare capital markets team of Managing Directors, Mariel Healy and Michael Campbell.

“We are delighted to welcome Brian to Cowen’s long-standing healthcare capital markets team, particularly at a time when experience is paramount as we advise our clients in the current landscape,” said Mr Miller. “Brian’s expertise and capabilities fit well with our team, and his proven track record of executing transactions in healthcare verticals will expand Cowen’s existing capabilities while delivering differentiated value to our clients. “

Mr. Hagerty joins Cowen at an important time as the financial services company expands its advisory business into healthcare, its most established industry sector. Today, Cowen Research covers approximately 350 healthcare companies and the company has completed over 90 transactions since the start of 2021, ranking second among all underwriters.

Mr. Hagerty said, “I am honored to join Cowen, a team that I have long respected for its customer focus, dedication to healthcare and range of world-class research, advisory and capital raising services. . I look forward to playing an active role in the next generation of Cowen Equity Capital Markets leaders on the Wall Street leadership team, especially now that a broader biotech and healthcare platform can have a positive and lasting impact on the business and among our customers.

Mr. Hagerty joins Cowen with over 10 years of capital markets experience. Previously, he served as Head of Healthcare Capital Markets Advisory at Matthews South, where he led healthcare origination for all products. Prior to that, Mr. Hagerty served as Head of Healthcare Capital Markets at Evercore. Previously, he served as Head of Healthcare Capital Markets at the New York Stock Exchange, and began his career at JP Morgan Chase, where he worked for seven years, primarily in equity capital markets. health care.

About Cowen Inc.
Cowen Inc. (“Cowen” or the “Company”) is a diversified financial services company that operates through two business segments: a brokerage and an investment management division. The Company’s brokerage division provides investment banking, equity and credit research, sales and trading, prime brokerage, global clearing and commission management services. Cowen’s Investment Management segment offers actively managed alternative investment products. Cowen Inc. is focused on providing value-added capabilities to our customers to help them outperform. Founded in 1918, the company is headquartered in New York and has offices around the world. Learn more about Cowen.com.

© 2022, COWEN INC., ALL RIGHTS RESERVED. COWEN AND COMPANY, LLC: MEMBER FINRA, NYSE AND SIPC

MEDIA CONTACT
Communication Gagnier
Dan Gagnier
[email protected]
646 569 5897